Interpace Biosciences (IDXG) Reports Q1 EPS of $0.03

Interpace Biosciences (OTC: IDXG) reported Q1 EPS of $0.03. Revenue for the quarter came in at $9.03 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Perion Network (PERI) call put ratio 13.2 calls to 1 put with a focus on 6400 contracts of October 7.5 calls
• United Airlines flies first Starlink-equipped widebody on transatlantic route